Efgartigimod

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

A Study of Efgartigimod in Patients With IgG4-Related Disease

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

Efgartigimod for Stiff Person Syndrome (ESPS)

Efgartigimod for the Treatment of Guillain-Barré Syndrome

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Seronegative Myasthenia Gravis - Efgartigimod IV

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)